Deferoxamine Mesylate Injection 500mg

Deferoxamine Mesylate Injection 500mg Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

• Deferoxamine  Mesylate Injection 500mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

• Deferoxamine Mesylate Injection 500mg
  As freeze-dried powder:
  Deferoxamine 500mg
  Eq. to Deferoxamine Injection………………………….500mg
  Excipients…………………………………………q.s.

THERAPEUTIC INDICATIONS:

Deferoxamine Mesylate Injection is used to remove excess iron from the body in anemia or thalassemia patients who have many blood transfusions. It is also used with other medicines to treat acute iron poisoning, especially in small children. Deferoxamine combines with iron in the blood.

CAUTION & WARNING:

• CAUTION:  flushing (a sense of warmth in the face, ears, neck and trunk), rash, decreased blood pressure and abdominal pain.
• Warning: for hospital use only.

STORAGE & DOSAGE:

• Storage: Store at 20° to 25°C (68° to 77°F).
• Dosage: As directed by the Physician

Introduction to Understanding Deferoxamine Mesylate Injection 500mg and Its Global Demand

Deferoxamine Mesylate Injection 500mg is a chelating agent widely prescribed for chronic iron overload, particularly in patients undergoing frequent blood transfusions due to thalassemia or anemia. It works by binding with excess iron in the bloodstream, forming complexes that are excreted naturally through urine, thereby preventing organ damage caused by iron accumulation.

Beyond chronic iron overload, this injection is also used for acute iron poisoning cases, especially among children, and sometimes in conditions requiring aluminum toxicity control in dialysis patients.

Globally, the demand for Deferoxamine Mesylate Injection 500mg has seen a sharp increase, with major healthcare systems in Asia, Africa, Europe, and Latin America requiring reliable suppliers. With rising cases of thalassemia and chronic transfusion therapies, the market demand is consistently growing, opening opportunities for reliable manufacturers like Taj Pharma India.

Taj Pharma is a leading Deferoxamine Mesylate Injection 500mg manufacturer, supplier, and exporter in India, known for WHO-GMP, EU-GMP, and international regulatory approvals.

Why Deferoxamine Mesylate Injection 500mg is Important for Patients

• Prevents iron toxicity in thalassemia patients.

• Reduces risk of heart, liver, and endocrine system damage.

• Used in acute poisoning emergencies.

• Safe, effective, and WHO-recommended treatment for iron overload.

However, patients may experience some side effects such as:

• Flushing

• Rash

• Low blood pressure

• Abdominal pain

• Dizziness

• Nausea or vomiting

Despite mild side effects, its therapeutic benefits far outweigh risks, making it an essential life-saving drug globally.

In-Depth Details for Importers/Exporters/Buyers

1. Regulatory Documentation Provided by Taj Pharma

Taj Pharma ensures smooth global registrations by providing:

• WHO-GMP Certification

• EU-GMP Approval

• Certificate of Pharmaceutical Product (CoPP)

• CTD/ACTD Dossier Support

• Bioequivalence & Stability Data

• Product Samples for Registration

2. Custom Packaging & Labeling

• Flexible pack sizes: Glass vials & ampoules.

• Private labeling services for distributors.

• Multilingual packaging (English, French, Spanish, Arabic, etc.).

3. Shelf-life, Storage, Dosage Form

• Dosage form: Lyophilized powder for injection.

• Strength: 500mg.

• Storage: Below 25°C, protect from moisture & light.

• Shelf-life: 24–36 months depending on market requirements.

4. Export Certifications

• WHO-GMP, EU-GMP, US-FDA compliant facilities

• ISO 9001:2015 certified

• Export compliant with ICH, PIC/S, and EMA standards

5. Target Countries & Export Markets

Taj Pharma successfully exports to over 40+ countries, including:

• Latin America: Brazil, Mexico, Peru

• Africa: Kenya, Nigeria, South Africa, Ghana

• CIS Nations: Ukraine, Kazakhstan, Uzbekistan

• Middle East: Saudi Arabia, UAE, Iraq, Jordan

• Asia-Pacific: Vietnam, Myanmar, Philippines

Why Taj Pharma is the Most Trusted Manufacturer, Supplier & Exporter

Taj Pharma India has carved a niche in the global pharmaceutical export market. Here’s why importers and buyers trust Taj Pharma for Deferoxamine Mesylate Injection 500mg:

State-of-the-Art Manufacturing

1. • WHO-GMP, EU-GMP certified facility in Vapi, Gujarat.

   • Automated sterile filling lines ensuring zero contamination.

     Affordable Pricing & Quality Assurance

     • Competitive pricing without compromising on quality or efficacy.

     • Stringent quality checks across every batch.

       Global Presence & Supply Chain Support

       • Strategic supply chains with PAN India distribution.

       • Strong logistics network ensures timely delivery worldwide.

         Top 20 Export Countries

         USA, UK, Mexico, Brazil, South Africa, Kenya, Nigeria, Vietnam, Myanmar, Philippines, Saudi Arabia, UAE, Yemen, Iraq, Sri Lanka, Nepal, Bangladesh, Ukraine, Kazakhstan, Peru.

Technical Product Specification Table

Are you a global buyer, distributor, or PCD pharma partner searching for a reliable Deferoxamine Mesylate Injection 500mg manufacturer in India?

👉 Contact Taj Pharma India today for best pricing, WHO-GMP quality, and global regulatory support.

📩 Email: info@tajpharma.com
🌐 Website: www.tajpharma.com

Top 20 FAQs

Q1. What is Deferoxamine Mesylate Injection 500mg used for?
It is used for treating iron overload caused by frequent blood transfusions and acute iron poisoning.

Q2. Is Taj Pharma a WHO-GMP certified manufacturer?
Yes, Taj Pharma operates from WHO-GMP & EU-GMP certified facilities in Vapi, India.

Q3. What is the shelf-life of this product?
Typically 24–36 months depending on market requirements.

Q4. Can Taj Pharma supply bulk orders globally?
Yes, Taj Pharma exports to 40+ countries with bulk supply capabilities.

Q5. What dosage form is available?
Lyophilized powder for intramuscular or intravenous injection.

Q6. Are private labeling services available?
Yes, Taj Pharma offers custom branding & packaging for distributors.

Q7. What are the side effects?
Common side effects include nausea, dizziness, rash, stomach pain, and low blood pressure.

Q8. What certifications are provided for export?
WHO-GMP, EU-GMP, CoPP, CTD Dossier, ISO.

Q9. Can it be used in children?
Yes, particularly in cases of iron poisoning under medical supervision.

Q10. Which countries does Taj Pharma export to?
Over 40 countries including USA, UK, Brazil, Kenya, Vietnam, and UAE.

Q11. How is the injection administered?
It is administered intramuscularly, subcutaneously, or intravenously by healthcare professionals.

Q12. Is Deferoxamine safe during pregnancy?
Not recommended without a doctor’s consultation.

Q13. Can it be combined with other iron chelators?
Only under medical supervision.

Q14. What is the recommended storage condition?
Store at below 25°C, away from light and moisture.

Q15. What is the MOQ for buyers?
Taj Pharma supports both small & large-scale buyers with flexible MOQs.

Q16. What makes Taj Pharma stand out among Indian manufacturers?
Global certifications, cost-effectiveness, and regulatory compliance.

Q17. Can Taj Pharma provide CTD dossiers?
Yes, complete regulatory support is provided.

Q18. What is the price range?
Pricing depends on order size & export destination, but Taj Pharma ensures affordability.

Q19. Is Deferoxamine Mesylate Injection available in PCD franchise model?
Yes, Taj Pharma offers PCD Pharma Franchise opportunities across India.

Q20. How to contact Taj Pharma for business?
Visit www.tajpharma.com or email info@tajpharma.com.